BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6490824)

  • 1. Latex agglutination test for detection of Clostridium difficile toxin in stool samples.
    Shahrabadi MS; Bryan LE; Gaffney D; Coderre SE; Gordon R; Pai CH
    J Clin Microbiol; 1984 Sep; 20(3):339-41. PubMed ID: 6490824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Clostridium difficile toxins A (enterotoxin) and B (cytotoxin) in clinical specimens. Evaluation of a latex agglutination test.
    Peterson LR; Holter JJ; Shanholtzer CJ; Garrett CR; Gerding DN
    Am J Clin Pathol; 1986 Aug; 86(2):208-11. PubMed ID: 3739972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of latex agglutination test for Clostridium difficile toxin A (D-1) and differentiation between C difficile toxins A and B and latex reactive protein.
    Borriello SP; Barclay FE; Reed PJ; Welch AR; Brown JD; Burdon DW
    J Clin Pathol; 1987 May; 40(5):573-80. PubMed ID: 3108333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commercial latex agglutination test for detection of Clostridium difficile-associated diarrhea.
    Kelly MT; Champagne SG; Sherlock CH; Noble MA; Freeman HJ; Smith JA
    J Clin Microbiol; 1987 Jul; 25(7):1244-7. PubMed ID: 3611316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of a rapid latex test for the detection of Clostridium difficile in fecal specimens.
    Ryan RW; Kwasnik I; Clout D; Tilton RC
    Ann Clin Lab Sci; 1987; 17(4):232-5. PubMed ID: 3619398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination.
    Staneck JL; Weckbach LS; Allen SD; Siders JA; Gilligan PH; Coppitt G; Kraft JA; Willis DH
    J Clin Microbiol; 1996 Nov; 34(11):2718-21. PubMed ID: 8897171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of six commercial assays for the rapid detection of Clostridium difficile toxin and/or antigen in stool specimens.
    Vanpoucke H; De Baere T; Claeys G; Vaneechoutte M; Verschraegen G
    Clin Microbiol Infect; 2001 Feb; 7(2):55-64. PubMed ID: 11298143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the latex agglutination test for detection of Clostridium difficile.
    Kelly WF; Wait KJ; Gilligan PH
    Arch Pathol Lab Med; 1992 May; 116(5):517-20. PubMed ID: 1580756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the VIDAS Clostridium difficile toxin A immunoassay with C. difficile culture and cytotoxin and latex tests.
    Shanholtzer CJ; Willard KE; Holter JJ; Olson MM; Gerding DN; Peterson LR
    J Clin Microbiol; 1992 Jul; 30(7):1837-40. PubMed ID: 1629341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of gas-liquid chromatography as a screening test for toxigenic Clostridium difficile in diarrhoeal stools.
    Pepersack F; Labbe M; Nonhoff C; Schoutens E
    J Clin Pathol; 1983 Nov; 36(11):1233-6. PubMed ID: 6630574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of four methods for detection of Clostridium difficile or C. difficile toxin: cytotoxin assay, culture, latex agglutination, and a new rapid immunoassay (C. difficile toxin A test).
    Fille M; Larcher C; Dierich MP; Allerberger F
    Z Gastroenterol; 1998 Feb; 36(2):143-9. PubMed ID: 9544497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of C. diff.-CUBE test for detection of Clostridium difficile-associated diarrhea.
    Kurzynski TA; Kimball JL; Schultz DA; Schell RF
    Diagn Microbiol Infect Dis; 1992 Aug; 15(6):493-8. PubMed ID: 1424501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
    Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
    Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of four methods in the diagnosis of Clostridium difficile disease.
    Mattia AR; Doern GV; Clark J; Holden J; Wu L; Ferraro MJ
    Eur J Clin Microbiol Infect Dis; 1993 Nov; 12(11):882-6. PubMed ID: 8112366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Clostridium difficile toxin A by reversed passive latex agglutination.
    Toma C; Nakamura S; Kamiya S; Nakasone N; Iwanaga M
    Microbiol Immunol; 1999; 43(8):737-42. PubMed ID: 10524790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal and specific polyclonal antibodies for immunoassay of Clostridium difficile toxin A.
    Lyerly DM; Phelps CJ; Wilkins TD
    J Clin Microbiol; 1985 Jan; 21(1):12-4. PubMed ID: 3968199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The problems of rapid diagnosis of Clostridium difficile as causative agent of antibiotic-associated pseudomembranous colitis].
    Lanzendörfer H; Wüst J; Altwegg M
    Schweiz Rundsch Med Prax; 1991 Jan; 80(1-2):15-9. PubMed ID: 1990415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations in the laboratory diagnosis of antibiotic-associated gastroenteritis.
    Ryan RW
    Diagn Microbiol Infect Dis; 1986 Mar; 4(3 Suppl):79S-86S. PubMed ID: 3516548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a latex agglutination test for Clostridium difficile in two nursing home outbreaks.
    Bennett RG; Laughon BE; Mundy LM; Bobo LD; Gaydos CA; Greenough WB; Bartlett JG
    J Clin Microbiol; 1989 May; 27(5):889-93. PubMed ID: 2745696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a commercial latex agglutination assay for screening for Clostridium difficile-associated disease.
    Stella PA
    Clin Lab Sci; 1994; 7(5):311-3. PubMed ID: 10150387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.